1PAUL-SAMOJEDNY M,WITEK A,SAMOJEDNY A,et al.Humantelomerase RNAas endogenous con-trol in endometrial tissue[].International Journal of Gynecological Cancer.2005
2O h St,et al.Telomerase activation by human papil-lomavirus type16E6protein:induction of human te-lomerase reverse treanscriptase expression through Myc and GC-rich Sp1binding sites[].J V iro l.2001
3KOMATA T,KOGAS,HIROHATAS,et al.Ano-vel treat ment of human malignant gliomas in vitro and in vivo:FADD genetransfer under the control of the human telomerase reversetranscriptase gene promoter[].International Journal of Oncology.2001
4Bryce LA,Morrison N,Hoare SF,et al.Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15. 33 by fluorescence in situ hybridization[].Neoplasia.2000
5Nakamura T,Morin GB,Chapman KB,et al.Telomerase catalytic subunit homolgs from fission yeast and human[].Science.1997
6Kyo S,Takakura M,Taira T,et al.Spl cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene(hTERT)[].Nucleic Acids Research.2000
7Oren M.Decision making by p53:life,death and cancer[].Cell Death and Differentiation.2003
8Komata T,Kondo Y,Kanzawa T,et al.Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter[].Cancer Research.2001
9Gu J,Andreeff M,Roth JA,et al.hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity[].Gene Therapy.2002
10Koga S,Hirohata S,Kondo Y,et al.A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter[].Human Gene Therapy.2000
同被引文献14
1SVENSON U,ROOS G.Telomere length as a biological marker in malignancy[J].Biochim Biophys Acta,2009,1792:317-323.
2ZHENG Y L,LOFFREDO C A,ALBERG A J,et al.Less efficient g2-m checkpoint is associated with an increased risk of lung cancer in African Americans[J].Cancer Res,2005,65:9566-9573.
3LIN K W,YAN J.The telomere length dynamic and methods of its assessment[J].J Cell Mol Med,2005,9:977-989.
4MARTENS U M,BRASS V,ENGELHARDT M,et al.Measurement of telomere length in haematopoietic cells using in situ hybridization techniques[J].Biochem Soc Trans,2000,28:245-250.
6YAN J,CHEN B Z,BOUCHARD E F,et al.The labeling efficiency of human telomeres is increased by double-strand PRINS[J].Chromosoma,2004,113:204-209.
7LANSDORP P M,VERWOERD N P,VAN DE RIJKE F M,et al.Heterogeneity in telomere length of human chromosomes[J].Hum Mol Genet,1996,5:685-691.
8DEWALD G,STALLARD R,AL SAADI A,et al.A multicenter investigation with interphase fluorescence in situ hybridization using X-and Y-chromosome probes[J].Am J Med Genet,1998,76:318-326.
9SHAFFER L G,SLOVAK M L,CAMPBELL I J.ISCN.An International System for Human Cytogenetic Nomenclature[M].Basel:karger,2009.
10COLGIN L,REDDEL R.Telomere biology:a new player in the end zone[J].Curr Biol,2004,14:R901-902.
